Brighton Jones LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 198.5% in the fourth quarter, HoldingsChannel reports. The firm owned 2,525 shares of the medical equipment provider’s stock after buying an additional 1,679 shares during the quarter. Brighton Jones LLC’s holdings in Intuitive Surgical were worth $921,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of ISRG. Cetera Investment Advisers purchased a new stake in Intuitive Surgical during the 2nd quarter worth about $756,000. Toronto Dominion Bank increased its position in Intuitive Surgical by 25.8% during the 2nd quarter. Toronto Dominion Bank now owns 12,503 shares of the medical equipment provider’s stock worth $11,693,000 after purchasing an additional 2,568 shares in the last quarter. WFG Advisors LP increased its position in Intuitive Surgical by 32.7% during the 2nd quarter. WFG Advisors LP now owns 853 shares of the medical equipment provider’s stock worth $798,000 after purchasing an additional 210 shares in the last quarter. USA Financial Portformulas Corp purchased a new stake in Intuitive Surgical during the 2nd quarter worth about $2,905,000. Finally, Lord Abbett & CO. LLC increased its position in Intuitive Surgical by 55.5% during the 2nd quarter. Lord Abbett & CO. LLC now owns 62,078 shares of the medical equipment provider’s stock worth $58,066,000 after purchasing an additional 22,152 shares in the last quarter. Hedge funds and other institutional investors own 36.79% of the company’s stock.

ISRG has been the subject of a number of recent research reports. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $409.00 price objective for the company in a research report on Wednesday, January 3rd. Wells Fargo & Co reiterated a “buy” rating on shares of Intuitive Surgical in a research report on Monday, October 16th. BidaskClub lowered Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, December 12th. Goldman Sachs Group reissued a “buy” rating on shares of Intuitive Surgical in a research note on Saturday, November 18th. Finally, Vetr raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $434.75 price target on the stock in a research note on Monday, January 8th. One research analyst has rated the stock with a sell rating, six have given a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $408.48.

Intuitive Surgical, Inc. (NASDAQ ISRG) opened at $398.51 on Tuesday. The firm has a market capitalization of $44,650.00, a PE ratio of 70.16, a PEG ratio of 4.63 and a beta of 0.50. Intuitive Surgical, Inc. has a 52 week low of $233.66 and a 52 week high of $452.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 25th. The medical equipment provider reported $2.54 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.27. The business had revenue of $892.40 million for the quarter, compared to analyst estimates of $866.54 million. Intuitive Surgical had a return on equity of 19.93% and a net margin of 21.09%. The company’s revenue was up 17.9% compared to the same quarter last year. During the same period in the previous year, the company posted $2.03 EPS. research analysts predict that Intuitive Surgical, Inc. will post 7.93 EPS for the current year.

In related news, EVP Curet Myriam sold 262 shares of the business’s stock in a transaction that occurred on Tuesday, January 30th. The stock was sold at an average price of $431.50, for a total transaction of $113,053.00. Following the transaction, the executive vice president now directly owns 2,152 shares of the company’s stock, valued at approximately $928,588. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Jamie Samath sold 959 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $398.46, for a total value of $382,123.14. Following the transaction, the vice president now directly owns 536 shares in the company, valued at $213,574.56. The disclosure for this sale can be found here. Insiders sold a total of 85,016 shares of company stock worth $35,133,026 over the last ninety days. Corporate insiders own 2.20% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Brighton Jones LLC Buys 1,679 Shares of Intuitive Surgical, Inc. (ISRG)” was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The correct version of this article can be read at https://theolympiareport.com/2018/02/13/brighton-jones-llc-buys-1679-shares-of-intuitive-surgical-inc-isrg.html.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.